Latest news
Can AstraZeneca (AZN) Reach Its $80 Billion Revenue Goal Despite Clinical Setbacks? - Yahoo Finance UKYahoo Finance UK · Mon, 10 Aug 2026 23:44:03 GMTStock Market Today: Live Updates 09.08.2026 - TechStock²TechStock² · Sun, 09 Aug 2026 08:00:03 GMTEEU’s Electrification Race Slows Despite Stronger Revenue Growth - Birr MetricsBirr Metrics · Fri, 07 Aug 2026 12:42:54 GMTSOUN Stock Hits 2-Month High, Rallying Toward Biggest Gain in 3 Months Despite Analyst Target Cuts - TradingViewTradingView · Thu, 06 Aug 2026 16:04:24 GMTRosenblatt keeps TeraWulf at Buy and $30 target despite lower estimates - Blockspace MediaBlockspace Media · Thu, 06 Aug 2026 14:48:12 GMTMaruti Suzuki Shares In Focus: Q1 Revenue Beat Keeps Nirmal Bang Bullish Despite Margin Pressure — Check Target Price - NDTV ProfitNDTV Profit · Mon, 03 Aug 2026 03:53:15 GMTModerna maintains 10% growth target despite Phase 3 norovirus miss - BioSpaceBioSpace · Fri, 31 Jul 2026 07:00:00 GMTGoldman, Barclays, Jefferies Cut Robinhood Targets Despite Earnings Beat - BeInCryptoBeInCrypto · Thu, 30 Jul 2026 07:00:00 GMT